Fonarow GC - Search Results

1

Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.

Lam PH, Packer M, Gill GS, Wu WC, Levy WC, Zile MR, Brar V, Arundel C, Cheng Y, Singh SN, Allman RM, Fonarow GC, Ahmed A. Lam PH, et al. Among authors: fonarow gc. Am J Med. 2020 Oct;133(10):1187-1194. doi: 10.1016/j.amjmed.2020.02.040. Epub 2020 Apr 6. Am J Med. 2020. PMID: 32272101 Free PMC article.

2

Predicting death from progressive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

Saxon LA, Stevenson WG, Middlekauff HR, Fonarow G, Woo M, Moser D, Stevenson LW. Saxon LA, et al. Am J Cardiol. 1993 Jul 1;72(1):62-5. doi: 10.1016/0002-9149(93)90220-7. Am J Cardiol. 1993. PMID: 8517430

3

Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure.

Fonarow GC, Stevenson LW, Walden JA, Livingston NA, Steimle AE, Hamilton MA, Moriguchi J, Tillisch JH, Woo MA. Fonarow GC, et al. J Am Coll Cardiol. 1997 Sep;30(3):725-32. doi: 10.1016/s0735-1097(97)00208-8. J Am Coll Cardiol. 1997. PMID: 9283532 Free article.

4

Skin test anergy in advanced heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy.

Vredevoe DL, Woo MA, Doering LV, Brecht ML, Hamilton MA, Fonarow GC. Vredevoe DL, et al. Among authors: fonarow gc. Am J Cardiol. 1998 Aug 1;82(3):323-8. doi: 10.1016/s0002-9149(98)00334-8. Am J Cardiol. 1998. PMID: 9708661

5

Improved survival in patients with nonischemic advanced heart failure and syncope treated with an implantable cardioverter-defibrillator.

Fonarow GC, Feliciano Z, Boyle NG, Knight L, Woo MA, Moriguchi JD, Laks H, Wiener I. Fonarow GC, et al. Am J Cardiol. 2000 Apr 15;85(8):981-5. doi: 10.1016/s0002-9149(99)00914-5. Am J Cardiol. 2000. PMID: 10760339

6

The relationship between obesity and mortality in patients with heart failure.

Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Woo MA, Tillisch JH. Horwich TB, et al. Among authors: fonarow gc. J Am Coll Cardiol. 2001 Sep;38(3):789-95. doi: 10.1016/s0735-1097(01)01448-6. J Am Coll Cardiol. 2001. PMID: 11527635 Free article.

7

The role of in-hospital initiation of cardioprotective therapies to improve treatment rates and clinical outcomes.

Fonarow GC. Fonarow GC. Rev Cardiovasc Med. 2002;3 Suppl 3:S2-S10. Rev Cardiovasc Med. 2002. PMID: 12447156 Review.

8

Heart failure: recent advances in prevention and treatment.

Fonarow GC. Fonarow GC. Rev Cardiovasc Med. 2000 Summer;1(1):25-33, 54. Rev Cardiovasc Med. 2000. PMID: 12457149 Review.

9

The role of in-hospital initiation of cardiovascular protective therapies to improve treatment rates and clinical outcomes.

Fonarow GC. Fonarow GC. Rev Cardiovasc Med. 2003;4 Suppl 3:S37-46. Rev Cardiovasc Med. 2003. PMID: 14564233 Review.

10

The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure.

Fonarow GC; ADHERE Scientific Advisory Committee. Fonarow GC, et al. Rev Cardiovasc Med. 2003;4 Suppl 7:S21-30. Rev Cardiovasc Med. 2003. PMID: 14668697 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,776 results

Search Page

Filters